Aier Eye Hospital announces restricted share release, subsidiary performance guarantee

Aier Eye Hospital Group announced that conditions for the fourth restricted share release period of its 2021 restricted stock incentive plan have been met as of September 22, 2025. This involves 198,798 restricted shares, representing 0.0021% of the company's total share capital, for three eligible incentive recipients. Due to a six-month lock-up period, these shares will remain restricted until March 21, 2026. The performance target for this period, a net profit growth rate of not less than 80% compared to 2020, was surpassed with a 110.96% increase in 2024 net profit.

Concurrently, Aier Eye Hospital Group approved a performance guarantee for its controlling subsidiary, Shaoguan Aier Eye Hospital Co., Ltd. The guarantee, amounting to no more than RMB 1.7 million, supports Shaoguan Aier's payment obligations for its relocation and expansion project. This guarantee brings the total accumulated external guarantees by the company and its subsidiaries over the past 12 months to RMB 7.7 million, representing 0.04% of the company's net assets as of the end of 2024.

Both resolutions were passed at the Sixth Board of Directors' Forty-Second Meeting on September 22, 2025.